Key result
This review examines the maternal and fetal considerations of NSAID use during pregnancy, highlighting the potential for 60-75 mg/day of aspirin to reduce preeclampsia and fetal growth retardation.
Why the study?
What are the maternal and fetal effects and safety considerations of NSAID use during pregnancy?
Population
Pregnant women and fetuses
Design
Review
Authors
Loading...
Low-dose aspirin may aid preeclampsia prevention; leaves open need for prospective NSAID safety trials.
What are the maternal and fetal effects and safety considerations of NSAID use during pregnancy?
This review outlines the pharmacological effects and safety considerations of NSAIDs in pregnancy, emphasizing the potential benefits of low-dose aspirin for preeclampsia prevention against historical safety fears.
Schoenfeld et al. (1992) conducted a review in Pregnancy. NSAIDs (indomethacin, aspirin) was evaluated. This review examines the maternal and fetal considerations of NSAID use during pregnancy, highlighting the potential for 60-75 mg/day of aspirin to reduce preeclampsia and fetal growth retardation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: